Should we perform surgery on late invasive vulvar cancer?

References

• Hacker NF. Vulvar cancer. In: Practical Gynecologic Oncology, 3rd Edition. Berek JS, Hacker NF (Eds). Lippincott Williams and Wilkins, PA, USA, 553–596 (2000).
   Google Scholar
• Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet. Gynecol.86, 51–54 (1995).
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi A, Freedman D, Miller D et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol. Oncol.84, 94–101 (2002).
   PubMed Web of Science ®Google Scholar
• Gaducci A, Cionini L, Romanini A et al. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit. Rev. Oncol. Hematol.60, 227–241 (2006).
   PubMedGoogle Scholar
• Benedet JL, Bender H, Jones H 3rd et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int. J. Gynecol. Obstet.70, 209–262 (2000).
   PubMed Web of Science ®Google Scholar
• Maggino T, Landoni F, Sartori E et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CFT study. Cancer89,116–122 (2000).
   PubMed Web of Science ®Google Scholar
• Paladini D, Cross P, Lopes A et al. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer74, 2491–2496 (1994).
   PubMed Web of Science ®Google Scholar
• Fanfani F, Garganese G, Fagotti A et al. Advanced vulvar carcinoma: it is worth operating? A perioperative management protocol for radical and reconstructive surgery. Gynecol. Oncol.103(2), 467–472 (2006).
   PubMedGoogle Scholar
• De Mooij Y, Burger MP, Schilthuis MS, et al. Partial urethral resection in the surgical treatment of vulvar cancer does not have a significant impact on urinary continence. A confirmation of an authority-based opinion. Int. J. Gynecol. Cancer17, 294–297 (2007).
   PubMed Web of Science ®Google Scholar
• Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer. Avoiding primary exenteration. Gynecol. Oncol.100, 53–57 (2006).
   PubMed Web of Science ®Google Scholar
• Weikel W, Schmidt M, Steiner E et al. Surgical therapy of recurrent vulvar cancer. Am. J. Obstet. Gynecol.195, 1293–1302 (2006).
   PubMed Web of Science ®Google Scholar
• Balat O, Edwards CL, Verschraegen C, Delclos L. The long term results of radiotherapy with or without surgery in management of advanced vulvar cancer. Report of 76 patients. Eur. J. Gynaecol. Oncol.21, 426–429 (2000).
   PubMedGoogle Scholar
• Van Doorn HC, Ansink A, Verhaar-Langreis M et al. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst. Rev.3, CD003752 (2006).
   Google Scholar
• Han SC, Kim DH, Higgins SA et al. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys.47, 1235–1244 (2000).
   PubMedGoogle Scholar
• Homesly HD. Management of vulvar cancer. Cancer76, 2159–2170 (1995).
   PubMedGoogle Scholar
• Van der Velden K, Ansink A. Primary groin irradiation vs primary groin surgery for early vulvar cancer. Cochrane Database Syst. Rev.4, CD00224 (2001).
   Google Scholar
• Beriwal S, Heron DH, Kim H et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. J. Radiat. Oncol. Biol. Phys.64, 1395–1400 (2006).
   PubMedGoogle Scholar
• Tewari K, Cappucini F, Syed AM et al. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am. J. Obstet. Gynecol.181, 91–98 (1999).
   PubMedGoogle Scholar
• Montana GS, Thomas GM, Moore DH et al. Preoperative chemoradiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys.48, 1007–1013 (2000).
   PubMed Web of Science ®Google Scholar
• Gerszten K, Selvaraj RN, Kelley J et al. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol. Oncol.99, 640–644 (2005).
   PubMedGoogle Scholar
• Moore DH, Thomas GM, Montana GS et al. Preoperative chemoradiation for advanced vulvar cancer: a Phase II study of Gynecologic Oncology Group. Int. J. Radiat. Oncol. Biol. Phys.48, 79–85 (1998).
   Google Scholar
• Cunningham MJ, Goyer RP, Gibbons SK et al. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol. Oncol.66, 51–56 (1997).
   Google Scholar
• Mulayim N, Foster-Silver D, Schwartz PE, et al. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol. Oncol.93, 659–666 (2004).
   PubMedGoogle Scholar
• Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol. Oncol.36, 423–427 (1990).
   PubMedGoogle Scholar
• Leibel SA, Fuks Z, Zelefsky MJ et al. Intensity-modulated radiotherapy. Cancer J.8, 164–176 (2002).
   PubMed Web of Science ®Google Scholar
• Blake P. Radiotherapy and chemotherapy for carcinoma of the vulva. Best Pract. Res. Clin. Obstet. Gynecol.17, 649–661 (2003).
   PubMed Web of Science ®Google Scholar
• Micha JP, Goldstein BH, Rettenmaier MA, et al. Pelvic radiation necrosis and osteomyelitis following chemoradiation for advanced stage vulvar and cervical carcinoma. Gynecol. Oncol.101, 349–352 (2006).
   PubMedGoogle Scholar
• De Hullu JA, van de Zee AG. Surgery and radiotherapy in vulvar cancer. Crit. Rev. Oncol. Hematol.60, 38–58 (2006).
   PubMed Web of Science ®Google Scholar
• Olejek A, Mazurek U, Orchel J et al. The assessment of expression of kininogen and bradykinin receptor genes in different vulvar pathologies by QPCR (TaqMan). Ginekol. Pol.72, 717–722 (2001).
   PubMedGoogle Scholar